Today: The Louisiana State Employees Retirement System lowers its Position in LivaNova PLC (LIVN)

The Louisiana State Employees Retirement System lowers its Position in LivaNova PLC (LIVN)

Louisiana State Employees Retirement System reduced its position in shares of LivaNova PLC (NASDAQ:LIVN) by 3.4% during the second quarter, Holdings Channel reports. The institutional investor owned 11,400 shares of the company’s stock after selling 400 shares during the period. Louisiana State Employees Retirement System’s holdings in LivaNova PLC were worth $573,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. Teachers Advisors Inc. increased its stake in shares of LivaNova PLC by 1.4% in the first quarter. Teachers Advisors Inc. now owns 64,793 shares of the company’s stock worth $3,498,000 after buying an additional 900 shares in the last quarter. LS Investment Advisors LLC boosted its position in shares of LivaNova PLC by 70.7% in the second quarter. LS Investment Advisors LLC now owns 2,840 shares of the company’s stock worth $143,000 after buying an additional 1,176 shares during the last quarter. UBS Group AG boosted its position in shares of LivaNova PLC by 15.6% in the first quarter. UBS Group AG now owns 10,520 shares of the company’s stock worth $567,000 after buying an additional 1,418 shares during the last quarter. A.R.T. Advisors LLC boosted its position in shares of LivaNova PLC by 3.4% in the first quarter. A.R.T. Advisors LLC now owns 54,115 shares of the company’s stock worth $2,921,000 after buying an additional 1,800 shares during the last quarter. Finally, 1832 Asset Management L.P. boosted its position in shares of LivaNova PLC by 3.4% in the first quarter. 1832 Asset Management L.P. now owns 54,600 shares of the company’s stock worth $4,922,000 after buying an additional 1,800 shares during the last quarter. 63.66% of the stock is currently owned by institutional investors and hedge funds.

Shares of LivaNova PLC (NASDAQ:LIVN) traded up 0.30% on Monday, hitting $56.62. 279,055 shares of the stock traded hands. LivaNova PLC has a 52-week low of $46.79 and a 52-week high of $70.95. The firm has a 50 day moving average price of $59.75 and a 200 day moving average price of $54.36. The firm’s market cap is $2.77 billion.

A number of brokerages have commented on LIVN. Piper Jaffray Cos. reiterated an “overweight” rating and set a $70.00 price target (up from $59.00) on shares of LivaNova PLC in a research report on Friday, August 5th. WBB Securities reiterated a “hold” rating and set a $60.00 price target on shares of LivaNova PLC in a research report on Wednesday, August 31st. Six analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $67.20.

In other LivaNova PLC news, major shareholder Two S.C.A. Equinox sold 208,000 shares of the stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $60.52, for a total value of $12,588,160.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jacques Gutedel sold 4,000 shares of the stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $60.52, for a total value of $242,080.00. Following the completion of the sale, the insider now owns 10,948 shares of the company’s stock, valued at $662,572.96. The disclosure for this sale can be found here. 0.70% of the stock is owned by company insiders.

About LivaNova PLC

LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing.

Related posts

Leave a Comment